The Federal Trade Commission (FTC) released a report finding that OptumRX, Express Scripts, and CVS Caremark Rx are engaged in widespread price gouging, according to Fortune. The investigation ...
The FTC sued CVS Caremark, OptumRx and Express Scripts and their group purchasing organizations in September accusing the companies of "rigging" the insulin market and driving up prices.